Article
Evolution towards extremely high β-lactam resistance in <i>Mycobacterium abscessus</i> outbreak strains
2024-05-10
Abstract excerpt
Treatment of Mycobacterium abscessus pulmonary disease requires multiple antibiotics including intravenous β-lactams (e.g., imipenem, meropenem). M. abscessus produces a β-lactamase (Bla Mab ) that inactivates β-lactam drugs but less efficiently carbapenems. Due to intrinsic and acquired resistance in M. abscessus and poor clinical outcomes, it is critical to understand the development of antibiotic resistance...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 226280ab-daf5-5937-bcc8-06aedad8e221
- DOI
- 10.1101/2024.05.08.593223
